A seizure becomes dangerously prolonged once it lasts roughly five minutes without stopping on its own, a threshold that marks the transition from a typical self-limiting seizure to a medical emergency called status epilepticus. Most seizures end within one to two minutes as the brain’s built-in braking systems kick in. When those mechanisms fail, the electrical storm keeps going and the risks climb steeply with every passing minute. Understanding what happens during a prolonged seizure, why the brain struggles to shut it down, and how treatment changes as the clock ticks is useful for anyone who lives with epilepsy or cares for someone who does.
The Five-Minute Rule and Why It Matters
For decades, status epilepticus was formally defined as a seizure lasting thirty minutes or longer. That definition was revised because waiting half an hour to act was clearly too long. An international task force now defines status epilepticus as a seizure that has gone on long enough for the brain’s normal termination mechanisms to have failed, with two critical time points. For convulsive (tonic-clonic) seizures, the first time point is five minutes: beyond that, the seizure is unlikely to stop by itself and should be treated as continuous seizure activity. The second time point is thirty minutes, after which the risk of lasting brain damage rises sharply.
These time points come from both animal experiments and clinical observation. They are not arbitrary cutoffs but reflect real biological transitions in what the brain is doing during a seizure. The five-minute mark is when emergency treatment should begin; the thirty-minute mark is when the consequences shift from reversible disruption to potential permanent injury, including neuronal death and rewiring of neural circuits.1PubMed. A definition and classification of status epilepticus–Report of the ILAE Task Force on Classification of Status Epilepticus
Why the Brain Cannot Stop Itself
Under normal circumstances, a seizure triggers its own shutdown. Inhibitory signals ramp up, excitatory neurons fatigue, and the episode fizzles out. In a prolonged seizure, that feedback loop breaks down. One key reason involves changes in the receptors that sit on the surface of neurons. During sustained seizure activity, the receptors responsible for inhibition get pulled off the cell surface and tucked inside the neuron, reducing the brain’s ability to calm itself. At the same time, excitatory receptors move in the opposite direction, migrating from inside the neuron to its surface, which amplifies the electrical storm already in progress.2Journal of Neuroscience. Trafficking of GABAA Receptors, Loss of Inhibition, and a Mechanism for Pharmacoresistance in Status Epilepticus
This receptor trafficking has a cruel practical consequence: the longer a seizure lasts, the harder it becomes to stop with standard medications. Benzodiazepines, the first-line drugs used to halt seizures, work by boosting inhibitory signaling through those very receptors that are disappearing from the cell surface. That means a drug given at two minutes into a seizure is far more likely to work than the same drug given at twenty minutes. The clock is not just ticking on brain damage; it is ticking on treatment effectiveness too.
How Prolonged Seizures Injure the Brain
When a seizure keeps going, excitatory chemical signals flood the space between neurons. One of the main culprits is glutamate. At normal levels, glutamate is essential for learning and memory. At the excessive levels produced during a prolonged seizure, it overactivates receptors and drives a massive surge of calcium into neurons. That calcium overload triggers cell death pathways, a process researchers call excitotoxicity.3PubMed Central. Role of glutamate excitotoxicity and glutamate transporter EAAT2 in epilepsy: Opportunities for novel therapeutics development
Beyond direct neuronal killing, prolonged seizures also damage the blood-brain barrier, the tightly sealed layer of cells that normally keeps the brain’s chemical environment tightly controlled. Preclinical research shows that seizure-induced breakdown of this barrier allows inflammatory molecules to leak into brain tissue, setting off a cascade of swelling and immune activation that can persist well after the seizure has stopped. That lingering inflammation may itself contribute to the development of epilepsy later on.4PubMed Central. The Roof is Leaking and a Storm is Raging: Repairing the Blood-Brain Barrier in the Fight Against Epilepsy
The body outside the brain suffers as well. Prolonged convulsive seizures can cause dangerously high body temperature, drops in blood oxygen, spikes in blood pressure followed by dangerous drops, buildup of lactic acid, and muscle breakdown severe enough to damage the kidneys. Status epilepticus is a whole-body crisis, not just a brain event.5PubMed. Systemic Complications of Status Epilepticus
First-Line Treatment Outside the Hospital
Most seizure emergencies begin at home, at school, or in public, far from an IV line. That reality has driven the development of rescue medications that caregivers can give without medical training. Intranasal midazolam, delivered as a spray into the nose, stops seizures faster than rectal diazepam and is quicker to administer than intravenous diazepam. Studies confirm that it works when given not just by emergency department staff but also by paramedics and family members at home.6PubMed. Intranasal therapies for acute seizures
Speed of delivery matters enormously here. Because of the receptor changes described earlier, a benzodiazepine given within the first few minutes of a seizure has the best chance of ending it. Waiting for an ambulance to arrive and start an IV wastes precious time. That is why rescue medications designed for home use exist: they bridge the gap between seizure onset and professional care. If you have a family member with epilepsy and their neurologist has prescribed a rescue medication, keeping it accessible and knowing how to use it is one of the most consequential things you can do.
What Happens When the First Drug Fails
If a benzodiazepine does not stop the seizure, the next step in the hospital is a second-line antiseizure medication given intravenously. For years, fosphenytoin was the default choice. A landmark trial compared three options head-to-head: levetiracetam, fosphenytoin, and valproate. The results were strikingly similar. Seizures stopped and the patient’s level of consciousness improved within sixty minutes in roughly 47% of those given levetiracetam, 45% with fosphenytoin, and 46% with valproate. None of the three clearly outperformed the others.7PubMed Central. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus
A secondary analysis of the same trial broke the results down by age. In children, the success rate hovered around 49% to 52% for all three drugs. In adults, it was in the mid-40s. In older adults, the numbers dipped somewhat, with valproate showing a slightly higher response rate than the other two, though the differences were not statistically meaningful.8The Lancet. Randomized Trial of Levetiracetam, Fosphenytoin, and Valproate for Established Status Epilepticus Out-of-Hospital/In-Emergency Departmenting by Age: A Secondary Analysis of the Established Status Epilepticus Treatment Trial (ESETT)
The practical takeaway is that clinicians now have real flexibility in choosing a second-line drug. The decision often comes down to the individual patient’s other medical conditions, potential drug interactions, and side-effect profile rather than any clear efficacy difference among the three.
Refractory and Super-Refractory Cases
When seizures continue despite two appropriate treatments, the situation is classified as refractory status epilepticus. At that point, patients typically require anesthetic agents delivered by continuous IV drip in an intensive care unit, with ongoing brain-wave monitoring. If seizures persist or return even after 24 hours of anesthesia, the condition is called super-refractory status epilepticus. This is the most dangerous end of the spectrum, associated with high mortality and severe disability in survivors.
Ketamine has emerged as a particularly interesting option in super-refractory cases, and the reason ties back to what is happening at the receptor level. Standard anesthetics used to control seizures work through the same inhibitory receptors that have already been depleted from the neuron surface. Ketamine takes a different approach: it blocks excitatory receptors instead. In one study, seizure burden dropped by at least half within 24 hours of starting ketamine in about 81% of patients, and seizures stopped completely in 63%.9PubMed Central. Ketamine to treat super-refractory status epilepticus A systematic review of the broader literature found seizure resolution rates ranging from about 53% to 91% in larger case series, with ketamine offering the additional advantage of supporting blood pressure rather than dropping it the way many sedatives do.10PubMed Central. Use of ketamine in Super Refractory Status Epilepticus: a systematic review
Evidence also suggests that ketamine works best when started early and at adequate doses. In more than 70% of studies examining seizure control within the first 48 hours, ketamine was effective, with higher doses appearing to produce better results.11Journal of Neurocritical Care. Refractory and super-refractory status epilepticus and evidence for the use of ketamine: a scope review Much of this evidence comes from case series and observational studies rather than randomized trials, so the strength of the data is moderate, but the direction of the findings is consistent.
The Seizure You Cannot See
Not all prolonged seizures involve convulsions. In non-convulsive status epilepticus, the brain is seizing electrically but the outward signs may be subtle: confusion, a blank stare, sluggish responses, or a fluctuating level of consciousness. In an intensive care unit, this can be nearly invisible, mistaken for sedation or the aftereffects of another illness. Diagnosis depends entirely on brain-wave monitoring, which requires specialized equipment and expertise that many hospitals lack.12PubMed Central. Diagnosis, treatment, and outcome prediction of non-convulsive status epilepticus in unconscious patients in intensive care units
Non-convulsive status epilepticus is especially treacherous because it can go on for days before anyone notices. In one study, patients who ultimately received continuous midazolam infusions for refractory non-convulsive seizures had been in status epilepticus for an average of nearly four days before targeted treatment began. Even once treatment started, breakthrough seizures were clinically subtle or entirely invisible on physical exam in 89% of cases, detectable only on continuous brain-wave monitoring.13PubMed. Continuous EEG monitoring and midazolam infusion for refractory nonconvulsive status epilepticus The longer it goes unrecognized, the worse the outcomes tend to be.
Prolonged Seizures in Children
The most common form of prolonged seizure in young children is febrile status epilepticus, a seizure triggered by fever that lasts thirty minutes or more. It is understandably terrifying for parents, but the short-term outlook is better than many people expect. A large study of children with febrile status epilepticus found no deaths and no new cases of cognitive or motor disability in the immediate aftermath.14PubMed. Short-term outcomes of children with febrile status epilepticus
That does not mean febrile status epilepticus is entirely harmless. Only about 10% of episodes stop on their own without medication, and of those children who did receive treatment, 78% needed more than one drug before the seizure finally stopped.15PubMed Central. Emergency Management of Febrile Status Epilepticus: Results of the FEBSTAT study MRI scans performed after febrile status epilepticus reveal changes in about 12% of children, most commonly increased signal in the hippocampus, the brain’s memory center. Developmental abnormalities of the hippocampus were also more common in children who had experienced febrile status epilepticus compared with controls.16PubMed Central. MRI abnormalities following febrile status epilepticus in children: the FEBSTAT study Whether these early hippocampal changes eventually lead to epilepsy or memory problems years down the road is an active area of research.
Can a Prolonged Seizure Cause Epilepsy?
One of the most important long-term risks of a prolonged seizure is that it may rewire the brain in ways that make future seizures more likely. Animal research has consistently shown that status epilepticus causes a characteristic pattern of cell death in the hippocampus, followed by a quiet period of weeks or months, followed by the emergence of recurrent spontaneous seizures that can persist indefinitely.17PubMed. The course of cellular alterations associated with the development of spontaneous seizures after status epilepticus 18PubMed. Epileptogenesis after self-sustaining status epilepticus
The human picture is harder to study with the same precision, but the clinical pattern mirrors the animal data. People who have experienced status epilepticus are at elevated risk for developing epilepsy afterward. This process, called epileptogenesis, is thought to involve a combination of cell loss, inflammation, formation of abnormal neural connections, and the blood-brain barrier damage described earlier. One of the great unsolved problems in epilepsy research is whether anything can be done during that silent interval to interrupt the process before chronic epilepsy takes hold.
Memory and Cognitive Effects
Memory is the cognitive function most vulnerable to prolonged seizures, and the reason is anatomical: the hippocampus, which is essential for forming new memories, sits in a region of the brain that is particularly susceptible to seizure-related damage. Longer and more frequent seizures are associated with more severe hippocampal shrinkage and greater memory impairment.19PubMed Central. Cognitive Impairment in People with Epilepsy
Longitudinal studies of adults with temporal lobe epilepsy, the form most closely tied to hippocampal damage, paint a sobering picture. In one study following patients over years, roughly half of those treated with medication alone and 60% of surgical patients showed significant memory decline, with relatively little change in other cognitive areas.20PubMed. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy Across multiple prospective studies, the pattern is consistent: the decline is real but tends to be mild to moderate, and memory is hit harder than general intelligence.21PubMed. Cognitive effects of seizures
This is one reason neurologists emphasize seizure control so forcefully. Every prolonged seizure is not just a medical emergency in the moment; it is a potential hit to long-term cognitive health, particularly memory.
Autoimmune Causes and NORSE
Sometimes prolonged seizures arrive out of nowhere in a person with no history of epilepsy, no obvious brain injury, and no structural abnormality on imaging. When this happens and the seizures prove refractory to standard treatment, clinicians increasingly consider an autoimmune cause. New-onset refractory status epilepticus, or NORSE, is a clinical scenario in which a previously healthy person develops relentless seizures that resist every standard intervention. Among cases where a cause is eventually identified, autoimmune encephalitis accounts for more than a third, followed by infection-related causes.22PubMed Central. Understanding new-onset refractory status epilepticus from an immunological point of view
Recognizing an autoimmune cause changes treatment fundamentally. Instead of piling on more antiseizure drugs, the focus shifts to calming the immune system with therapies like high-dose steroids, plasma exchange, or newer anti-inflammatory agents. NORSE remains rare, but its identification has reshaped how doctors approach unexplained refractory seizures, prompting earlier testing for autoimmune antibodies and earlier use of immunotherapy.
Emerging Therapies for the Toughest Cases
For super-refractory status epilepticus, where conventional drugs and even anesthetics have failed, a range of unconventional approaches are being explored. One of the most intriguing is allopregnanolone, a naturally occurring brain steroid that enhances inhibitory signaling through a different mechanism than benzodiazepines. In case reports of pediatric patients with super-refractory seizures, allopregnanolone allowed anesthetic drips to be weaned off while the seizures resolved.23PubMed Central. Pediatric super-refractory status epilepticus treated with allopregnanolone
Other approaches under active investigation include therapeutic hypothermia (cooling the brain to reduce metabolic demand), the ketogenic diet (which shifts the brain’s fuel source in ways that may reduce seizure activity), electrical brain stimulation, and even emergency epilepsy surgery in highly selected cases.24PubMed Central. Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management None of these has been validated in large randomized trials for this specific setting, but for patients whose seizures have resisted everything else, they represent genuine options rather than last-ditch guesswork.
The Cost and Burden Beyond the Hospital
Surviving a prolonged seizure is only the beginning of recovery. Patients who have experienced status epilepticus frequently need weeks or months of rehabilitation, and many never return to their pre-event baseline. The financial burden is substantial. Intensive care stays, continuous brain-wave monitoring, and multiple rounds of medications add up quickly, and in resource-limited settings the picture is even worse, where limited availability of ICU beds compounds the clinical challenge.25PubMed. Clinical outcomes and healthcare costs in status epilepticus: A multivariable analysis from a tertiary center in a resource-limited setting
People with certain genetic epilepsy syndromes face a disproportionate share of this burden. In a large cohort study of patients with genetic developmental and epileptic encephalopathies, the overall mortality rate was about 6 per 1,000 person-years, with sudden unexpected death in epilepsy accounting for nearly half of all deaths. Specific gene variants, including those in the SCN1A and SCN8A genes, carried the highest risk.26PubMed Central. Rates of Status Epilepticus and Sudden Unexplained Death in Epilepsy in People With Genetic Developmental and Epileptic Encephalopathies For families caring for children with these conditions, the threat of a prolonged seizure is not a one-time emergency but a recurring shadow, making seizure action plans, rescue medication access, and close communication with a neurologist indispensable parts of daily life.